Jon Hopkins New Senior Vice President-Chief Development Officer of Legion Healthcare Partners

Jon Hopkins brings to Legion more than 25 years of experience in healthcare, primarily in radiation oncology hardware, software, education, training, strategic planning, and execution.

“Partnering with large medical systems to bring lifesaving, proton therapy treatment options to thousands of patients around the US is our core mission. When defining and laying the groundwork for this position and hire, it was paramount that we employ someone with exceptional personal and professional relationships in oncology, significant knowledge in the particle therapy space and most important, a well thought of leader, with a high moral and ethical compass. We are thrilled to have Jon’s fresh vision, energy and experience to help meet Legion’s mission of supporting those who need cancer care and those who provide that care,” said John Styles, Legion’s Chairman and Chief Executive Officer.

Over the past 23 years, Jon Hopkins has held various positions at Varian Medical Systems including Director of Sales, Americas West & Latin America, Varian Proton Solutions and prior Director of Worldwide Sales, Varian Particle Therapy. Jon Hopkins has provided leadership, sales and or support to over 17 proton therapy centers both domestically and internationally.

“I am thrilled to join the extraordinary team at Legion Healthcare Partners. It’s truly a wonderful opportunity to make a real difference, working alongside colleagues I’ve known, both personally and professionally for decades. I’m also excited to bring over 23 years of proton therapy and radiation oncology experience and knowledge which will assist our current and future clinical partners with solutions for the delivery of this this innovative and lifesaving technology both domestically and internationally,” says Mr. Hopkins.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.